Apparent diffusion coefficient measurements in progressive supranuclear palsy

被引:0
|
作者
T. Ohshita
M. Oka
Y. Imon
S. Yamaguchi
Y. Mimori
S. Nakamura
机构
[1] Third Department of Internal Medicine,
[2] Hiroshima University School of Medicine,undefined
[3] 1-2-3 Kasumi,undefined
[4] Minami-ku,undefined
[5] Hiroshima 734-8551,undefined
[6] Japan e-mail: ohshitat@mcai.med. hiroshima-u.ac.jp Tel.: + 81-82-2 57-52 01 Fax: + 81-82-5 05-04 90,undefined
来源
Neuroradiology | 2000年 / 42卷
关键词
Key words Progressive supranuclear palsy; Magnetic resonance imaging; Diffusion-weighted imaging;
D O I
暂无
中图分类号
学科分类号
摘要
We measured the apparent diffusion coefficient (ADC), using diffusion-weighted imaging (DWI) and signal intensity on T2-weighted MRI in the cerebral white matter of patients with progressive supranuclear palsy (PSP) and age-matched normal subjects. In PSP, ADC in the prefrontal and precentral white matter was significantly higher than in controls. There was no significant difference in signal intensity on T2-weighted images. The ADC did correlate with signal intensity. The distribution of the elevation of ADC may be the consequence of underlying pathological changes, such as neurofibrillary tangles or glial fibrillary tangles in the cortex. Our findings suggest that ADC measurement might be useful for demonstrating subtle neuropathological changes.
引用
收藏
页码:643 / 647
页数:4
相关论文
共 50 条
  • [31] Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy
    Shoichi Ito
    Takahiro Makino
    Wakako Shirai
    Takamichi Hattori
    Neuroradiology, 2008, 50 : 981 - 985
  • [32] Diagnostic accuracy of progressive supranuclear palsy in the society for progressive supranuclear palsy brain bank
    Josephs, KA
    Dickson, DW
    MOVEMENT DISORDERS, 2003, 18 (09) : 1018 - 1026
  • [33] Dystonia in progressive supranuclear palsy
    Barclay, CL
    Lang, AE
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1997, 62 (04): : 352 - 356
  • [34] Update on progressive supranuclear palsy
    Litvan I.
    Current Neurology and Neuroscience Reports, 2004, 4 (4) : 296 - 302
  • [35] Diplopia in Progressive Supranuclear Palsy
    Yazdi, Narges
    Ghamsari, Mona Ramezani
    Shoeibi, Ali
    Rohani, Mohammad
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (02): : 232 - 233
  • [36] Pain in Progressive Supranuclear Palsy
    Schlesinger, Ilana
    Klesier, Ana
    Yarnitskv, David
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (03) : 163 - 164
  • [37] Dysarthria in progressive supranuclear palsy
    Mallien, G.
    Hinterberger, K.
    Ostwald, A.
    Loeper, M.
    Lorenzi, S.
    Ziegler, W.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S63 - S64
  • [38] CT IN PROGRESSIVE SUPRANUCLEAR PALSY
    AMBROSETTO, P
    AMERICAN JOURNAL OF NEURORADIOLOGY, 1987, 8 (05) : 849 - 851
  • [39] Zolpidem in progressive supranuclear palsy
    Daniele, A
    Moro, E
    Bentivoglio, AR
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07): : 543 - 544
  • [40] Pseudonystagmus in progressive supranuclear palsy
    Ticku, Hemani
    Fotedar, Neel
    Juncos, Jorge
    Factor, Stewart A.
    Shaikh, Aasef G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 434